X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (60383) 60383
Newsletter (84) 84
Book Chapter (39) 39
Magazine Article (26) 26
Newspaper Article (17) 17
Book / eBook (13) 13
Publication (12) 12
Dissertation (9) 9
Conference Proceeding (5) 5
Journal / eJournal (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53227) 53227
female (31953) 31953
male (29575) 29575
oncology (29068) 29068
lung neoplasms - pathology (28007) 28007
middle aged (26541) 26541
aged (24001) 24001
carcinoma, non-small-cell lung - pathology (22878) 22878
cancer (18812) 18812
adult (16782) 16782
prognosis (15862) 15862
lung cancer (14086) 14086
neoplasm staging (13277) 13277
metastasis (11234) 11234
carcinoma (11186) 11186
tumors (10961) 10961
aged, 80 and over (10680) 10680
chemotherapy (10185) 10185
expression (10063) 10063
cell line, tumor (9657) 9657
lung neoplasms - drug therapy (9475) 9475
carcinoma, non-small-cell lung - drug therapy (9269) 9269
lung neoplasms - genetics (8702) 8702
lung cancer, non-small cell (8639) 8639
survival (8577) 8577
animals (8453) 8453
immunohistochemistry (8285) 8285
carcinoma, non-small-cell lung - genetics (7822) 7822
research (7331) 7331
analysis (7309) 7309
apoptosis (7295) 7295
pathology (6935) 6935
treatment outcome (6894) 6894
care and treatment (6875) 6875
surgery (6853) 6853
lung neoplasms - mortality (6826) 6826
respiratory system (6700) 6700
retrospective studies (6582) 6582
lung neoplasms - metabolism (6549) 6549
gene expression (6379) 6379
gene expression regulation, neoplastic (6178) 6178
carcinoma, non-small-cell lung - mortality (6156) 6156
non-small cell lung cancer (5754) 5754
mice (5737) 5737
survival rate (5628) 5628
mutation (5546) 5546
proteins (5536) 5536
lung neoplasms - surgery (5415) 5415
carcinoma, non-small-cell lung - metabolism (5408) 5408
medical prognosis (5340) 5340
cell biology (5300) 5300
genetic aspects (5271) 5271
survival analysis (5228) 5228
carcinoma, squamous cell - pathology (5131) 5131
adenocarcinoma (5100) 5100
carcinoma, non-small-cell lung - surgery (4857) 4857
health aspects (4656) 4656
development and progression (4624) 4624
medicine & public health (4585) 4585
cancer therapies (4559) 4559
adenocarcinoma - pathology (4554) 4554
patients (4514) 4514
antineoplastic combined chemotherapy protocols - therapeutic use (4349) 4349
breast-cancer (4301) 4301
cell proliferation (4292) 4292
squamous cell carcinoma (4054) 4054
research article (4001) 4001
metastases (3987) 3987
medicine (3985) 3985
disease-free survival (3965) 3965
lung-cancer (3850) 3850
diagnosis (3848) 3848
follow-up studies (3845) 3845
kinases (3759) 3759
radiotherapy (3671) 3671
lymphatic metastasis (3603) 3603
signal transduction (3522) 3522
non-small cell lung carcinoma (3463) 3463
biomarkers (3455) 3455
kaplan-meier estimate (3446) 3446
antineoplastic agents - therapeutic use (3433) 3433
cancer research (3433) 3433
studies (3410) 3410
growth (3366) 3366
hematology, oncology and palliative medicine (3342) 3342
therapy (3342) 3342
risk factors (3329) 3329
multidisciplinary sciences (3307) 3307
breast cancer (3261) 3261
disease progression (3188) 3188
proliferation (3145) 3145
biomarkers, tumor - metabolism (3094) 3094
biochemistry & molecular biology (3038) 3038
lung neoplasms - therapy (3033) 3033
cell lung-cancer (3028) 3028
carcinoma, non-small-cell lung - secondary (2924) 2924
neoplasm invasiveness (2921) 2921
nsclc (2900) 2900
biomarkers, tumor - genetics (2881) 2881
genes (2877) 2877
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Periodical Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (58721) 58721
Chinese (919) 919
French (452) 452
Japanese (444) 444
German (332) 332
Spanish (92) 92
Russian (87) 87
Polish (76) 76
Italian (65) 65
Turkish (23) 23
Hungarian (20) 20
Czech (16) 16
Portuguese (16) 16
Dutch (15) 15
Korean (13) 13
Bulgarian (12) 12
Romanian (11) 11
Serbian (8) 8
Danish (7) 7
Norwegian (7) 7
Croatian (6) 6
Finnish (5) 5
Icelandic (5) 5
Lithuanian (5) 5
Hebrew (4) 4
Arabic (1) 1
Bosnian (1) 1
Slovak (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 18, pp. 1700 - 1709
Patients with non–small-cell lung cancer and mutated epidermal growth factor receptors who develop resistance to EGFR inhibitors through a particular mutation (T790M... 
TYROSINE KINASE INHIBITORS | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | GEFITINIB | ADENOCARCINOMA | ACQUIRED-RESISTANCE | MUTATIONS | AFATINIB | ERLOTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Humans | Middle Aged | ErbB Receptors - genetics | Lung Neoplasms - pathology | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Acrylamides - pharmacokinetics | Dose-Response Relationship, Drug | Hyperglycemia - chemically induced | Antineoplastic Agents - adverse effects | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | ErbB Receptors - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidines - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Acrylamides - administration & dosage | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Acrylamides - adverse effects | Clinical trials | Care and treatment | Usage | Diagnosis | Lung cancer, Non-small cell | Hyperglycemia | Chemotherapy | Epidermal growth factor | Inhibitor drugs | Epidermal growth factor receptors | Lung cancer | Genes | Non-small cell lung carcinoma | Antitumor activity | Pharmacokinetics | Patients | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 22, pp. 2078 - 2092
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2011, Volume 103, Issue 19, pp. 1452 - 1460
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared with TRT alone has been shown to confer a survival advantage for good performance status patients with stage III non-small cell lung cancer... 
IRRADIATION | CARBOPLATIN | CISPLATIN | VINORELBINE | ONCOLOGY | THERAPY-ONCOLOGY-GROUP | CHEMORADIOTHERAPY | RADIOTHERAPY | CHEMOTHERAPY | RADIATION-THERAPY | PACLITAXEL | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | United States | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Time Factors | Vinblastine - adverse effects | Aged, 80 and over | Adult | Dose Fractionation | Chemotherapy, Adjuvant | Odds Ratio | Radiotherapy, Adjuvant | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Etoposide - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Disease Progression | Canada | Confounding Factors (Epidemiology) | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Etoposide | Research | Lung cancer, Non-small cell | Drug therapy | Radiotherapy | Health aspects | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 20, pp. 1919 - 1929
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 5, pp. 1352 - 1358
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 21, pp. 2027 - 2039
In a randomized trial involving patients with ALK -rearranged lung cancer, brigatinib was associated with longer progression-free survival and more activity... 
MEDICINE, GENERAL & INTERNAL | CERITINIB | EML4-ALK FUSION GENE | RESISTANCE | OPEN-LABEL | KINASE INHIBITOR | SINGLE-ARM | EGFR | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Organophosphorus Compounds - adverse effects | Crizotinib - therapeutic use | Lung Neoplasms - chemistry | Anaplastic Lymphoma Kinase - analysis | Kaplan-Meier Estimate | Organophosphorus Compounds - therapeutic use | Crizotinib - adverse effects | Pyrimidines - therapeutic use | Progression-Free Survival | Pyrimidines - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Anaplastic Lymphoma Kinase - antagonists & inhibitors | Crizotinib | Cancer patients | Safety and security measures | Development and progression | Dosage and administration | Comparative analysis | Lung cancer, Non-small cell | Drug therapy | Health aspects | Nuclear magnetic resonance--NMR | Medical imaging | Statistical analysis | Lung cancer | Non-small cell lung carcinoma | Metastasis | Radiation therapy | Lymphoma | Cancer therapies | Chemotherapy | Technical communication | Mutation | Protein-tyrosine kinase | Drug dosages | Pharmaceuticals
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9804, pp. 1727 - 1740
Summary In the decade since the last Lancet Seminar on lung cancer there have been advances in many aspects of the classification, diagnosis, and treatment of non-small-cell lung cancer (NSCLC... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | FORTHCOMING 7TH EDITION | MEDICINE, GENERAL & INTERNAL | STAGING PROJECT | POSITRON-EMISSION-TOMOGRAPHY | VINORELBINE PLUS CISPLATIN | RANDOMIZED PHASE-III | TRIALIST ASSOCIATION ANITA | TNM CLASSIFICATION | INTERNATIONAL-ASSOCIATION | RADIATION-THERAPY | Lymph Node Excision | Lymph Nodes - pathology | Prognosis | Volatile Organic Compounds - metabolism | Lung Neoplasms - mortality | Humans | Lung Neoplasms - pathology | Tomography, X-Ray Computed | Lung - diagnostic imaging | Positron-Emission Tomography | Pneumonectomy | Radiotherapy, Image-Guided | Multimodal Imaging | Neoplasm Grading | Thoracic Surgery, Video-Assisted | Carcinoma, Non-Small-Cell Lung - pathology | Genetic Predisposition to Disease | Risk Assessment | Biomarkers, Tumor - analysis | Terminology as Topic | Clinical Trials as Topic | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Mass Screening | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Biomarkers, Tumor - genetics | Exhalation | Neoplasm Staging | Early Diagnosis | Conferences, meetings and seminars | Lung cancer, Non-small cell | Diagnosis | Fees & charges | Pathology | Brain | Lung cancer | Clinical trials | Mutation | Radiation therapy | Cancer therapies
Journal Article